Clinical Trials Directory

Trials / Completed

CompletedNCT00781586

Efficacy of ONE A DAY Weightsmart Advanced Versus Caffeine and Placebo on Energy Expenditure, Thermogenesis and Perceived Energy Levels in Women.

A Randomized, Single Center, Double-blind, Three-way Crossover Trial to Evaluate the Efficacy of ONE A DAY Weightsmart Advanced Versus Caffeine and Placebo on Energy Expenditure, Thermogenesis and Perceived Energy Levels in Women.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Bayer · Industry
Sex
Female
Age
25 Years – 45 Years
Healthy volunteers
Accepted

Summary

The study is considered research because efficacy (how well a drug works) information is needed in healthy, 25-45 year-old, female subjects with moderate caffeine intake. The investigational product is available in the United States without a prescription (over-the-counter) as a nutritional supplement. The purpose of this study is to assess whether One-A-Day Weightsmart Advanced is safe and can increase metabolism and perceived energy in female subjects compared with caffeine or placebo (inactive drug). Participation in this study will last approximately 4 weeks and require about 4 outpatient visits to St. Luk's-Roosevelt Hospital Center. About 21 subjects are expected to participate in this study.

Detailed description

\- Primary efficacy endpoints are area under the curve (AUC) over the first 2 hours and the last 2 hours of Resting Metabolic RateRespiratory Quotient- The secondary efficacy endpoints are:Perceived Energy scales Visual Analog Scale (VAS) Change from baseline for Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP) respiration, average heart rate over 1st 20 minutes, average heart rate over last 20 minutes, and temperature

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOne-A-Day Weight S.A. (Multi-Vitamins, BAY94-9350)One A Day Weight Smart Advanced 1 tablet at 1st visit
DRUGCaffeineCaffeine 100 mg 1 tablet at 1st visit
DRUGPlaceboPlacebo 1 tablet at 1st visit

Timeline

Start date
2007-10-02
Primary completion
2008-04-21
Completion
2008-04-21
First posted
2008-10-29
Last updated
2018-12-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00781586. Inclusion in this directory is not an endorsement.